X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (160) 160
index medicus (115) 115
female (99) 99
male (99) 99
infectious diseases (81) 81
adult (80) 80
tuberculosis (79) 79
middle aged (63) 63
microbiology (60) 60
respiratory system (42) 42
aged (38) 38
adolescent (35) 35
antitubercular agents - therapeutic use (35) 35
pharmacology & pharmacy (32) 32
pulmonary tuberculosis (31) 31
diagnosis (29) 29
treatment outcome (27) 27
sputum - microbiology (25) 25
tuberculosis - drug therapy (24) 24
mycobacterium tuberculosis - isolation & purification (23) 23
rifampin (23) 23
tuberculosis, pulmonary - drug therapy (23) 23
antitubercular agents - pharmacology (22) 22
infection (22) 22
mycobacterium tuberculosis - drug effects (22) 22
moxifloxacin (21) 21
mycobacterium tuberculosis - genetics (21) 21
mycobacterium-tuberculosis (21) 21
retrospective studies (21) 21
child (20) 20
immunology (20) 20
infectious disease (20) 20
netherlands (20) 20
nontuberculous mycobacteria (20) 20
pharmacokinetics (20) 20
young adult (20) 20
mycobacterium tuberculosis (19) 19
public, environmental & occupational health (19) 19
drug therapy (18) 18
epidemiology (18) 18
tuberculosis - microbiology (18) 18
hiv (17) 17
medicine (17) 17
mycobacterium infections, nontuberculous - microbiology (17) 17
rifampicin (17) 17
antitubercular agents - administration & dosage (16) 16
dna, bacterial - genetics (16) 16
health aspects (16) 16
microbial sensitivity tests (16) 16
research (16) 16
risk factors (16) 16
aged, 80 and over (15) 15
drugs (15) 15
identification (15) 15
malawi (15) 15
mycobacterium - isolation & purification (15) 15
public health (15) 15
resistance (15) 15
animals (14) 14
genotype (14) 14
hiv infections - complications (14) 14
tropical medicine (14) 14
atypical mycobacteria (13) 13
care and treatment (13) 13
drug therapy, combination (13) 13
malawi - epidemiology (13) 13
mycobacterium - classification (13) 13
rifampin - administration & dosage (13) 13
tanzania (13) 13
africa (12) 12
antitubercular agents (12) 12
bacterial typing techniques (12) 12
child, preschool (12) 12
ethambutol (12) 12
infant (12) 12
infections (12) 12
mycobacteria (12) 12
mycobacterium infections, nontuberculous - epidemiology (12) 12
netherlands - epidemiology (12) 12
patients (12) 12
tuberculosis, pulmonary - epidemiology (12) 12
tuberculosis, pulmonary - microbiology (12) 12
bacterial proteins - genetics (11) 11
drug resistance (11) 11
drug resistance, bacterial (11) 11
human-immunodeficiency-virus (11) 11
medicine, general & internal (11) 11
mycobacterium (11) 11
mycobacterium infections - microbiology (11) 11
mycobacterium infections, nontuberculous - drug therapy (11) 11
phylogeny (11) 11
prevalence (11) 11
rifampin - pharmacokinetics (11) 11
sequence analysis, dna (11) 11
sputum (11) 11
strains (11) 11
tuberculosis, pulmonary - diagnosis (11) 11
antitubercular agents - adverse effects (10) 10
bacteria (10) 10
children (10) 10
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


European Respiratory Journal, ISSN 0903-1936, 2013, Volume 42, Issue 6, pp. 1604 - 1613
Journal Article
by Ahmad, Nafees and Ahuja, Shama D and Akkerman, Onno W and Alffenaar, Jan-Willem C and Anderson, Laura F and Baghaei, Parvaneh and Bang, Didi and Barry, Pennan M and Bastos, Mayara L and Behera, Digamber and Benedetti, Andrea and Bisson, Gregory P and Boeree, Martin J and Bonnet, Maryline and Brode, Sarah K and Brust, James C M and Cai, Ying and Caumes, Eric and Cegielski, J Peter and Centis, Rosella and Chan, Pei-Chun and Chan, Edward D and Chang, Kwok-Chiu and Charles, Macarthur and Cirule, Andra and Dalcolmo, Margareth Pretti and D'Ambrosio, Lia and de Vries, Gerard and Dheda, Keertan and Esmail, Aliasgar and Flood, Jennifer and Fox, Gregory J and Fréchet-Jachym, Mathilde and Fregona, Geisa and Gayoso, Regina and Gegia, Medea and Gler, Maria Tarcela and Gu, Sue and Guglielmetti, Lorenzo and Holtz, Timothy H and Hughes, Jennifer and Isaakidis, Petros and Jarlsberg, Leah and Kempker, Russell R and Keshavjee, Salmaan and Khan, Faiz Ahmad and Kipiani, Maia and Koenig, Serena P and Koh, Won-Jung and Kritski, Afranio and Kuksa, Liga and Kvasnovsky, Charlotte L and Kwak, Nakwon and Lan, Zhiyi and Lange, Christoph and Laniado-Laborín, Rafael and Lee, Myungsun and Leimane, Vaira and Leung, Chi-Chiu and Leung, Eric Chung-Ching and Li, Pei Zhi and Lowenthal, Phil and Maciel, Ethel L and Marks, Suzanne M and Mase, Sundari and Mbuagbaw, Lawrence and Migliori, Giovanni B and Milanov, Vladimir and Miller, Ann C and Mitnick, Carole D and Modongo, Chawangwa and Mohr, Erika and Monedero, Ignacio and Nahid, Payam and Ndjeka, Norbert and O'Donnell, Max R and Padayatchi, Nesri and Palmero, Domingo and Pape, Jean William and Podewils, Laura J and Reynolds, Ian and Riekstina, Vija and Robert, Jérôme and Rodriguez, Maria and Seaworth, Barbara and Seung, Kwonjune J and Schnippel, Kathryn and Shim, Tae Sun and Singla, Rupak and Smith, Sarah E and Sotgiu, Giovanni and Sukhbaatar, Ganzaya and Tabarsi, Payam and Tiberi, Simon and Trajman, Anete and Trieu, Lisa and Udwadia, Zarir F and van der Werf, Tjip S and Veziris, Nicolas and Viiklepp, Piret and ... and Collaborative Grp Meta-Analysis In and Collaborative Group for the Meta-Analysis of Individual Patient Data in MDR-TB treatment–2017
The Lancet, ISSN 0140-6736, 09/2018, Volume 392, Issue 10150, pp. 821 - 834
Treatment outcomes for multidrug-resistant tuberculosis remain poor. We aimed to estimate the association of treatment success and death with the use of... 
DRUG | SURGERY | SOUTH-AFRICA | BEDAQUILINE | MEDICINE, GENERAL & INTERNAL | HIGH-RATES | MANAGEMENT | SAFETY | XDR-TB | REGIMENS | PROGRAM | Clofazimine - therapeutic use | Recurrence | Tuberculosis, Multidrug-Resistant - mortality | Linezolid - therapeutic use | Humans | Fluoroquinolones - therapeutic use | Tuberculosis, Pulmonary - drug therapy | Kanamycin - therapeutic use | Moxifloxacin | Capreomycin - therapeutic use | Amikacin - therapeutic use | Carbapenems - therapeutic use | Tuberculosis, Pulmonary - mortality | Diarylquinolines - therapeutic use | Treatment Failure | Antitubercular Agents - administration & dosage | Levofloxacin - therapeutic use | Drug Therapy, Combination | Antitubercular Agents - therapeutic use | Tuberculosis, Multidrug-Resistant - drug therapy | Drug resistance in microorganisms | Care and treatment | Tuberculosis | Patient outcomes | Analysis | Drugs | Fluoroquinolones | Linezolid | Levofloxacin | Amikacin | Medical services | Clinical trials | Systematic review | Drug resistance | Success | Clinical outcomes | Literature reviews | Heterogeneity | Kanamycin | Data analysis | Clofazimine | Adjustment | Mortality | Data processing | Thorax | Regression analysis | Disease control | Patients | Capreomycin | Meta-analysis | Studies | Multidrug resistant organisms | Infectious diseases | Adults | Respiration | Carbapenems
Journal Article
Lancet Infectious Diseases, The, ISSN 1473-3099, 2017, Volume 17, Issue 1, pp. 39 - 49
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 11/2017, Volume 61, Issue 11
In a multiple-dose-ranging trial, we previously evaluated higher doses of rifampin in patients for 2 weeks. The objectives of the current study were to... 
Tuberculosis | Pharmacokinetics | Drug safety | Rifampin | TRIAL | rifampin | drug safety | tuberculosis | DRUGS | pharmacokinetics | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | PHARMACODYNAMICS | MODEL | DOSE RIFAMPIN | AUTOINDUCTION
Journal Article
Leukemia, ISSN 0887-6924, 04/2018, Volume 32, Issue 4, pp. 931 - 940
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 1098-6596, 02/2015, Volume 59, Issue 2
Journal Article
American Journal of Respiratory and Critical Care Medicine, ISSN 1073-449X, 2015, Volume 191, Issue 9, pp. 1058 - 1065
Journal Article
by Akkerman, Onno and Aleksa, Alena and Alffenaar, Jan-Willem and Al-Marzouqi, Nada Hassan and Arias-Guillén, Miguel and Belilovski, Evgeny and Bernal, Enrique and Boeree, Martin J and Borisov, Sergey E and Bruchfeld, Judith and Cadiñanos Loidi, Julen and Cai, Qingshan and Caminero, Jose A and Cebrian Gallardo, Jose Joaquín and Centis, Rosella and Codecasa, Luigi Ruffo and D’Ambrosio, Lia and Dalcolmo, Margareth and Danila, Edvardas and Dara, Masoud and Davidavičienė, Edita and Davies Forsman, Lina and De Los Rios Jefe, Jorge and Denholm, Justin and Duarte, Raquel and Elamin, Seifeldin Eltaeb and Ferrarese, Maurizio and Filippov, Alexey and Ganatra, Shashank and Garcia, Ana and García-García, José-María and Gayoso, Regina and Giraldo Montoya, Angela Maria and Gomez Rosso, Roscio Gomez and Gualano, Gina and Hoefsloot, Wouter and Ilievska-Poposka, Biljana and Jonsson, Jerker and Khimova, Elena and Kuksa, Liga and Kunst, Heinke and Laniado-Laborín, Rafael and Li, Yang and Magis-Escurra, Cecile and Manfrin, Vinicio and Manga, Selene and Marchese, Valentina and Martínez Robles, Elena and Maryandyshev, Andrei and Matteelli, Alberto and Migliori, Giovanni Battista and Mullerpattan, Jai B and Munoz-Torrico, Marcela and Mustafa Hamdan, Hamdan and Nieto Marcos, Magnolia and Noordin, Noorliza Mohamad and Palmero, Domingo Juan and Palmieri, Fabrizio and Payen, Marie-Christine and Piubello, Alberto and Pontali, Emanuele and Pontarelli, Agostina and Quirós, Sarai and Rendon, Adrian and Skrahina, Alena and Šmite, Agnese and Solovic, Ivan and Sotgiu, Giovanni and Souleymane, Mahamadou Bassirou and Spanevello, Antonio and Stošić, Maja and Tadolini, Marina and Tiberi, Simon and Udwadia, Zarir Farokh and van den Boom, Martin and Vescovo, Marisa and Viggiani, Pietro and Visca, Dina and Zhurkin, Dmitry and Zignol, Matteo and Int Study Grp New AntiTB Drugs Adv and members of the International Study Group on new anti-tuberculosis drugs and adverse events monitoring
International Journal of Infectious Diseases, ISSN 1201-9712, 06/2019, Volume 83, pp. 72 - 76
The World Health Organization launched a global initiative, known as aDSM (active TB drug safety monitoring and management) to better describe the safety... 
MDR-TB | Tuberculosis | Adverse events | Delamanid | Monitoring | Bedaquiline | INFECTIOUS DISEASES | Complications and side effects | Drug resistance in microorganisms | Antitubercular agents | Drug therapy
Journal Article
Respiratory Medicine, ISSN 0954-6111, 10/2017, Volume 131, pp. 220 - 224
The incidence of non-tuberculous mycobacterial pulmonary disease (NTM-PD) has increased in the Netherlands. The fibro-cavitary disease manifestation... 
Pulmonary infections | MAC-PD | M. avium complex | Non tuberculous mycobacteria | M. avium complex | CARDIAC & CARDIOVASCULAR SYSTEMS | THERAPY | RESPIRATORY SYSTEM | HIV-NEGATIVE PATIENTS | CLINICAL-RELEVANCE | MALMOENSE | Humans | Middle Aged | Male | Tuberculosis, Pulmonary - drug therapy | Tuberculosis, Pulmonary - complications | Netherlands | Tinnitus - chemically induced | Rifamycins - therapeutic use | Bronchiectasis - diagnostic imaging | Female | Retrospective Studies | Mycobacterium avium Complex | Ethambutol - therapeutic use | Chemical and Drug Induced Liver Injury - etiology | Hearing Loss - chemically induced | Antitubercular Agents - therapeutic use | Nontuberculous Mycobacteria | Mycobacterium kansasii | Mycobacterium avium-intracellulare Infection - complications | Treatment Outcome | Mycobacterium Infections, Nontuberculous - diagnostic imaging | Mycobacterium abscessus | Mycobacterium Infections, Nontuberculous - complications | Mycobacterium avium-intracellulare Infection - drug therapy | Tuberculosis, Pulmonary - diagnostic imaging | Aged | Macrolides - therapeutic use | Mycobacterium avium-intracellulare Infection - diagnostic imaging | Gastrointestinal Diseases - chemically induced | Mycobacterium Infections, Nontuberculous - drug therapy | Bronchiectasis - etiology | Lung diseases | Tuberculosis | Chronic diseases | Medicine, Experimental | Medical research | Laboratories | Infections | Thorax | Rifamycin | Patients | Rifamycins | Hearing loss | Studies | Human immunodeficiency virus--HIV | Ethambutol | Chronic obstructive pulmonary disease | Tinnitus | Females | Hepatotoxicity | Index Medicus
Journal Article
Journal Article